Recommended Topic Related To:

Follistim

"Oct. 20, 2012 -- Babies conceived with the help of high-tech fertility treatments such as in vitro fertilization (IVF) have an increased risk for birth defects, a new study shows.

Compared to infants born to mothers who conceived with"...

Follistim AQ

Overdosage
Contraindications

OVERDOSE

Aside from the possibility of Ovarian Hyperstimulation Syndrome (see WARNINGS - Overstimulation of the Ovary During Follistim® AQ (follitropin beta) Therapy) and multiple gestations (see WARNINGS - Multiple Births), there is no additional information concerning the consequences of acute overdosage with Follistim® AQ (follitropin beta injection).

CONTRAINDICATIONS

Follistim® AQ (follitropin beta injection) is contraindicated in women who exhibit:

  1. Prior hypersensitivity to recombinant hFSH products.
  2. High levels of FSH indicating primary ovarian failure.
  3. Uncontrolled thyroid or adrenal dysfunction.
  4. Tumor of the ovary, breast, uterus, hypothalamus or pituitary gland.
  5. Pregnancy.
  6. Heavy or irregular vaginal bleeding of undetermined origin.
  7. Ovarian cysts or enlargement not due to polycystic ovary syndrome (PCOS).
  8. Hypersensitivity reactions to streptomycin or neomycin. Follistim® AQ (follitropin beta) may contain traces of these antibiotics and may cause hypersensitivity reactions in susceptible persons.

Last reviewed on RxList: 11/17/2008
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications
A A A

Follistim AQ - User Reviews

Follistim AQ User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Follistim AQ sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Trying to Conceive

Get tips and advances in treatment.